Scarica l'app Stockscreener
3.68
0.55%
0.02
Dopo l'orario di chiusura:
3.69
0.010
+0.27%
Precedente Chiudi:
$3.66
Aprire:
$3.68
Volume 24 ore:
460.96K
Relative Volume:
1.45
Capitalizzazione di mercato:
$198.55M
Reddito:
$2.76M
Utile/perdita netta:
$-49.12M
Rapporto P/E:
-2.4533
EPS:
-1.5
Flusso di cassa netto:
$-46.21M
1 W Prestazione:
+28.22%
1M Prestazione:
+45.45%
6M Prestazione:
+28.67%
1 anno Prestazione:
-34.98%
Intervallo 1D:
$3.55
$3.80
Intervallo di 1 settimana:
$2.8567
$3.80
Portata 52W:
$2.20
$6.50
Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile
Nome
Orchestra Biomed Holdings Inc
Settore
Industria
Telefono
646-343-9298
Indirizzo
150 UNION SQUARE DRIVE, NEW HOPE
Confronta OBIO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OBIO
Orchestra Biomed Holdings Inc
|
3.68 | 192.08M | 2.76M | -49.12M | -46.21M | -1.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-20 | Downgrade | BTIG Research | Buy → Neutral |
| 2025-03-20 | Iniziato | BTIG Research | Buy |
| 2025-01-02 | Iniziato | Barclays | Overweight |
| 2024-08-22 | Iniziato | H.C. Wainwright | Buy |
| 2024-07-25 | Iniziato | B. Riley Securities | Buy |
| 2024-01-19 | Iniziato | Jefferies | Buy |
| 2023-02-24 | Iniziato | Piper Sandler | Overweight |
| 2023-02-07 | Iniziato | Chardan Capital Markets | Buy |
Mostra tutto
Orchestra Biomed Holdings Inc Borsa (OBIO) Ultime notizie
Is Orchestra BioMed Holdings Inc a good long term investmentTechnology Stock Trends & High Return Wealth Building - earlytimes.in
Tools to monitor Orchestra BioMed Holdings Inc. recovery probability2025 Winners & Losers & Verified Technical Signals - newser.com
Applying chart zones and confluence areas to Orchestra BioMed Holdings Inc.2025 Valuation Update & Weekly High Return Opportunities - newser.com
Using data filters to optimize entry into Orchestra BioMed Holdings Inc.Long Setup & Community Trade Idea Sharing - newser.com
Orchestra BioMed to Highlight AVIM Therapy’s Potential to Transform Hypertension Care - MyChesCo
Will Orchestra BioMed Holdings Inc. stock beat EPS estimates2025 Market Overview & Verified High Yield Trade Plans - newser.com
Can Orchestra BioMed Holdings Inc. stock reach $100 price target2025 Trading Volume Trends & Expert Approved Momentum Trade Ideas - newser.com
Orchestra BioMed Holdings Inc. stock momentum explained2025 Dividend Review & Community Shared Stock Ideas - newser.com
Orchestra BioMed (NASDAQ:OBIO) Given Sell (E+) Rating at Weiss Ratings - MarketBeat
What does recent volatility data suggest for Orchestra BioMed Holdings Inc.July 2025 Patterns & Risk Controlled Swing Alerts - newser.com
Orchestra BioMed to Showcase Transformative Potential of - GlobeNewswire
Orchestra BioMed to Showcase Transformative Potential of AVIM Therapy in Keynote Presentation on Hypertensive Heart Disease at Georgia Innovation Summit - Investing News Network
Orchestra BioMed Presents Comprehensive Data on AVIM Therapy for Hypertensive Heart Disease at Georgia Innovation Summit - Quiver Quantitative
15.6 mmHg Immediate aSBP Drop — Orchestra BioMed AVIM Data; FDA Breakthrough, Oct 10 - Stock Titan
What’s next for Orchestra BioMed Holdings Inc. stock priceJuly 2025 Opening Moves & Advanced Technical Signal Analysis - newser.com
Orchestra BioMed Reports Q1 2025 Financial Results and Advances Key Clinical Programs - MSN
Full technical analysis of Orchestra BioMed Holdings Inc. stockTrade Analysis Report & Weekly High Return Stock Forecasts - newser.com
A activityEarnings Summary Report & Weekly High Potential Stock Alerts - newser.com
What institutional flow reveals about Orchestra BioMed Holdings Inc.Long Setup & Consistent Income Trade Ideas - newser.com
Why Orchestra BioMed Holdings Inc. stock is seen as undervaluedPortfolio Gains Summary & Accurate Trade Setup Notifications - newser.com
Evaluating Orchestra BioMed Holdings Inc. with trendline analysis2025 Geopolitical Influence & AI Enhanced Trading Signals - newser.com
Automated trading signals detected on Orchestra BioMed Holdings Inc.Market Movement Recap & High Accuracy Swing Entry Alerts - newser.com
Orchestra BioMed : Corporate Presentation October 2025 - MarketScreener
Published on: 2025-09-29 00:02:42 - newser.com
What analysts say about Orchestra BioMed Holdings Inc stockDividend Stock Watch & Interactive Learning for Better Returns - earlytimes.in
Orchestra Biomed Holdings Hits New 52-Week Low at $2.33 - Markets Mojo
Orchestra Biomed Holdings Hits New 52-Week Low at $2.20 - Markets Mojo
Orchestra Biomed Holdings Inc Azioni (OBIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Orchestra Biomed Holdings Inc Azioni (OBIO) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Fain Eric S | Director |
Aug 25 '25 |
Buy |
2.61 |
5,760 |
15,034 |
71,709 |
| Sherman Darren | See Remarks |
Aug 25 '25 |
Buy |
2.62 |
3,000 |
7,860 |
926,837 |
| Hochman David P | See Remarks |
Aug 21 '25 |
Buy |
2.49 |
6,000 |
14,940 |
651,460 |
| Taylor Andrew Lawrence | Chief Financial Officer |
Aug 25 '25 |
Buy |
2.55 |
2,000 |
5,100 |
482,788 |
| PERCEPTIVE ADVISORS LLC | 10% Owner |
Aug 01 '25 |
Buy |
2.75 |
700,000 |
1,925,000 |
5,292,556 |
| Hochman David P | See Remarks |
Aug 04 '25 |
Buy |
2.75 |
20,000 |
55,000 |
349,331 |
| Fain Eric S | Director |
Jun 26 '25 |
Sale |
3.05 |
2,683 |
8,183 |
50,949 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):